Genta, Inc (fka GNTAQ)

[chrisboker]

ON August 14th...BTW this does not Say AGENDA

"The last several months have been extraordinarily important", said Dr. Raymond P. Warrell, Jr., Genta's Chief Executive Officer. "We now believe we will have sufficient financing that will enable release of primary data in our Phase 3 Genasense® trial in melanoma. Certainly, past and recent studies of other drugs in melanoma have proved repeatedly disappointing. We believe our biomarker-directed approach, coupled with our uniquely targeted new drug, may transform the treatment of this illness and finally offer meaningful benefit for patients. We expect to release results from our Phase 3 study within the next 3 months, which if positive should comprise the basis for worldwide regulatory applications."

The Company's landlord received a termination payment of $1.3 million, comprised of security deposits, and will receive a future payment of $2.0 million on January 1, 2011.